Bococizumab is a remarkable anti-PCSK9 antibody specifically developed to treat hypercholesterolemia. Such therapeutic agent functions through the PCSK9 protein, a essential regulator of cholesterol levels. By blocking https://mediajx.com/story27573206/bococizumab-a-novel-anti-pcsk9-antibody-for-hypercholesterolemia